Monoclonal Gammopathy of Undetermined Significance
📧 Sign up to get email alerts when something new happens for Monoclonal Gammopathy of Undetermined Significance.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-10-01Clinical Trial Update: Daratumumab for Polyneuropathy Associated With MGUS [Phase 2]
A Phase 2 trial of daratumumab for polyneuropathy associated with monoclonal gammopathy of undetermined significance has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-03Clinical Trial Update: B-Cell Hematologic Malignancy Vaccination Registry
A clinical trial update indicates that the B-cell hematologic malignancy vaccination registry (NCT02298816) sponsored by Wake Forest Univers…